SELLAS Life Sciences (SLS) Property, Plant & Equipment (Net) (QoQ) (2011 - 2017)
SELLAS Life Sciences (SLS) Property, Plant & Equipment (Net) (QoQ) (2011 - 2017) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | SELLAS Life Sciences | 1.89 Bn | 1.78 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | -16.89% |
| Jun 30, 2017 | -14.45% |
| Mar 31, 2017 | -13.07% |
| Dec 31, 2016 | -11.95% |
| Sep 30, 2016 | -12.74% |
| Jun 30, 2016 | -13.38% |
| Mar 31, 2016 | -10.75% |
| Dec 31, 2015 | 16.32% |
| Sep 30, 2015 | -45.86% |
| Jun 30, 2015 | 0.76% |
| Mar 31, 2015 | 85.26% |
| Dec 31, 2014 | -51.61% |
| Sep 30, 2014 | -5.46% |
| Jun 30, 2014 | -4.59% |
| Mar 31, 2014 | -1.80% |
| Dec 31, 2013 | 22.02% |
| Sep 30, 2013 | 16.70% |
| Jun 30, 2013 | 1,629.63% |
| Mar 31, 2013 | -6.90% |
| Dec 31, 2012 | -6.45% |